Search for: "Ortho-McNeil Pharmaceutical" Results 121 - 140 of 270
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2010, 9:48 am by Bob Kraft
” The “case centers on drug safety claims that J&J and its Ortho-McNeil-Janssen Pharmaceutical unit made in November 2003 correspondence to 700,000 doctors. [read post]
4 Oct 2010, 3:51 am by Bob Kraft
" The "case centers on drug safety claims that J&J and its Ortho-McNeil-Janssen Pharmaceutical unit made in November 2003 correspondence to 700,000 doctors. [read post]
21 Sep 2010, 12:42 am by admin
TRADEMARK NOTICE: “Levaquin” is a trademark of Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development. [read post]
9 Sep 2010, 7:09 pm
See Ortho-McNeil Pharm., Inc. v. [read post]
29 Jul 2010, 10:14 am
Johnson & Johnson has agreed to a $75 Million national settlement related to allegations that its subsidiary, Ortho-McNeil-Janssen Pharmaceuticals schemed to improperly market the drug Topamax for uses that were not approved by the Food & Drug Administration. [read post]
28 Jul 2010, 12:06 am by Kelly
(EDTexweblog.com) (Docket Report) US: Post-Bilski: Federal Circuit to reconsider diagnostic testing and medical methods – Prometheus v Mayo, Classen v Biogen (IP Spotlight) (Patently-O) US: Federal Circuit review of patent term extensions – Ortho-McNeil v Lupin, Photocure v Kappos (Patently-O) USPTO provides clarification regarding treatment of PTA letters (Patent Docs) US: Pharmaceutical reverse payments and lower drug costs: An interesting dilemma! [read post]
21 Jul 2010, 1:05 am by Kelly
Biogaran and Laboratoires Medidom (EPLAW) Fortical (Calcitonin) – US: Unigene secures ruling of infringement against Apotex in Fortical patent suit (Patent Docs) Levaquin (Levofloxacin) – US: Federal Circuit denies rehearing petition in Levaquin Patent Term Extension case: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
20 Jul 2010, 12:56 pm by mcarzima@imediainc.com
In April of 2010, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, both subsidiaries of Johnson & Johnson, agreed to pay over $81 million to settle criminal and civil liability claims arising from the illegal promotion of the drug Topamax. [read post]
19 Jul 2010, 1:12 pm by FDABlog HPM
’s (“Lupin’s”) Petition for Rehearing en banc of a May 10, 2010 panel decision in Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Jul 2010, 10:39 pm by Carey, Danis & Lowe, L.L.C.
Texas resident Kenneth Edward Adams has filed the newest lawsuit against Levaquin makers Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development as of June 29 of 2010. [read post]
14 Jul 2010, 6:47 pm by Kelly
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for… [read post]
28 Jun 2010, 3:50 am by Steve McConnell
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
22 Jun 2010, 9:45 pm by Patent Docs
Kappos and Ortho-McNeil Pharmaceutical, Inc. v. [read post]
28 May 2010, 9:30 am by admin
May 10, 2010) (80 PTCJ 56, 5/14/10), and Ortho-McNeil Pharmaceutical Inc. v. [read post]
27 May 2010, 3:20 am
(Patent Docs) Levaquin (Levofloxacin) – US: When it comes to patent term extensions, an enantiomer is a different drug from racemate: Ortho-McNeil Pharma v. [read post]
25 May 2010, 7:54 am by Ed Wallis
Ortho-McNeil Pharmaceutical LLC, 10-CR-10147, US District Court, District of Massachusetts (Boston). [read post]